| Product NDC: | 0135-0459 |
| Proprietary Name: | Panadol |
| Non Proprietary Name: | acetaminophen and phenylephrine HCl |
| Active Ingredient(s): | 500; 5 mg/1; mg/1 & nbsp; acetaminophen and phenylephrine HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0135-0459 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110831 |
| Package NDC: | 0135-0459-03 |
| Package Description: | 50 POUCH in 1 CARTON (0135-0459-03) > 2 TABLET in 1 POUCH (0135-0459-01) |
| NDC Code | 0135-0459-03 |
| Proprietary Name | Panadol |
| Package Description | 50 POUCH in 1 CARTON (0135-0459-03) > 2 TABLET in 1 POUCH (0135-0459-01) |
| Product NDC | 0135-0459 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | acetaminophen and phenylephrine HCl |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110831 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 500; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |